[go: up one dir, main page]

WO2003068791A3 - Macrolides actifs contre staphylococcus aureus resistant a la methicilline - Google Patents

Macrolides actifs contre staphylococcus aureus resistant a la methicilline Download PDF

Info

Publication number
WO2003068791A3
WO2003068791A3 PCT/US2003/004130 US0304130W WO03068791A3 WO 2003068791 A3 WO2003068791 A3 WO 2003068791A3 US 0304130 W US0304130 W US 0304130W WO 03068791 A3 WO03068791 A3 WO 03068791A3
Authority
WO
WIPO (PCT)
Prior art keywords
staphylococcus aureus
activity against
resistant staphylococcus
compounds
macrolides
Prior art date
Application number
PCT/US2003/004130
Other languages
English (en)
Other versions
WO2003068791A2 (fr
Inventor
Zhenkun Ma
Robert Keyes
Stevan Djuric
Hong Yong
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/075,012 external-priority patent/US20030162729A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of WO2003068791A2 publication Critical patent/WO2003068791A2/fr
Publication of WO2003068791A3 publication Critical patent/WO2003068791A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés actifs contre des staphylocoques dorés résistants à la méthicilline (MRSA), ces composés étant représentés par la formule (I). Elle concerne aussi des sels, des promédicaments de ces composés, des procédés de fabrication de ces composés et des intermédiaires utilisés dans les procédés, des compositions contenant ces composés, et des méthodes de prophylaxie et de traitement d'infections dues aux staphylocoques dorés résistants à la méthicilline, au moyen de ces composés.
PCT/US2003/004130 2002-02-13 2003-02-11 Macrolides actifs contre staphylococcus aureus resistant a la methicilline WO2003068791A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/075,012 US20030162729A1 (en) 2002-02-13 2002-02-13 Macrolides with activity against methicillin-resistant staphylococcus aureus
US10/075,012 2002-02-13
US36147103A 2003-02-10 2003-02-10
US10/361,471 2003-02-10

Publications (2)

Publication Number Publication Date
WO2003068791A2 WO2003068791A2 (fr) 2003-08-21
WO2003068791A3 true WO2003068791A3 (fr) 2004-01-22

Family

ID=27736826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/004130 WO2003068791A2 (fr) 2002-02-13 2003-02-11 Macrolides actifs contre staphylococcus aureus resistant a la methicilline

Country Status (1)

Country Link
WO (1) WO2003068791A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055168A1 (fr) * 1999-03-15 2000-09-21 Abbott Laboratories Macrolides substitues en 6-o a activite antibacterienne

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055168A1 (fr) * 1999-03-15 2000-09-21 Abbott Laboratories Macrolides substitues en 6-o a activite antibacterienne

Also Published As

Publication number Publication date
WO2003068791A2 (fr) 2003-08-21

Similar Documents

Publication Publication Date Title
HUP0400446A2 (hu) Azitromicin kristályformái
WO2006120563A3 (fr) Agents antibacteriens
AU3196900A (en) Preventives/remedies for interstitial pneumonia and pulmonary fibrosis
WO2004062601A3 (fr) Agents antibacteriens
WO2007044032A3 (fr) Préparations à effet antiviral et antibactérien important
AU2003216485A1 (en) Process for antimicrobial treatment of fresh produce, particularly mushrooms
WO2007067559A3 (fr) Agents antibacteriens
WO2004080391A3 (fr) Nouveaux agents antibacteriens
EP1594444A3 (fr) Methodes et compositions destinees au traitement et a la prevention d'infections a staphylocoque ou autres infections bacteriennes
MX2010004407A (es) Antibioticos de carbacefem beta-lactama.
DE602004004808D1 (de) Acyloxymethylcarbamat-prodrugs von oxazolidinonen
WO2008133669A3 (fr) Inhibiteurs viraux
NZ594675A (en) Actagardine derivatives
NZ545472A (en) 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
WO2002064574A3 (fr) Antibactériens à base de pyridoarylphényle oxazolidinone, compositions et procédés associés
WO2005070945A8 (fr) Nouvel aminoside efficace contre le staphylococcus aureus resistant a la methicilline (mrsa)
WO2008014108A3 (fr) Promédicaments d'oxazolidinone antimicrobiens
WO2004043928A3 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones
WO2004098500A3 (fr) Beta-lactamine de la classe des carbacephems
CA2380455A1 (fr) 9a-azalides a activite antibacterienne
WO2003068791A3 (fr) Macrolides actifs contre staphylococcus aureus resistant a la methicilline
WO2004007489A3 (fr) Antibacteriens a base de methylenepiperidinophenyl oxazolidinones a substitution cyano ciblant de multiples sites de ribonucleoproteines
WO2002018353A3 (fr) Agents chimiotherapeutiques d'oxazolidinone
WO2004014316A3 (fr) Composes, compositions et techniques de traitement et de prevention de l'infection par des pneumovirus et de maladies associees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA CN JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)